DMD and Duchenne muscular dystrophy: In conclusion, we identified a total of 23 prognostic indicators of disease progression in DMD, of which cardiac medication, DMD genetic modifiers, DMD mutation type, and glucocorticoid exposure were designated core indicators significantly affecting a wide range of clinical outcomes.